Sign In
Buy IHE
$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026
California mulling private-label generics to address high drug costs
03:05pm, Thursday, 09'th Jan 2020
The new budget proposed by California Governor Gavin Newsom includes a plan to allow the state to contract with generic drug makers to provide medicines to all Californians. He believes that the gover
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
01:10pm, Friday, 20'th Dec 2019
Sector ETF report for PPH
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
12:00am, Friday, 20'th Dec 2019Pharma ETFs Set to Benefit Post Strong Q3 Earnings
04:00pm, Wednesday, 06'th Nov 2019
Robust results led to solid trading in pharma ETFs in a month.
JNJ Beats, Ups View: Healthcare ETFs to Buy
02:05pm, Wednesday, 16'th Oct 2019
Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.
Johnson & Johnson, UnitedHealth Give Healthcare ETFs a Much Needed Bolster Shot
10:43pm, Tuesday, 15'th Oct 2019
Healthcare stocks and sector-related exchange traded funds found support from a strong start to the earnings season after UnitedHealth Group (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ) provided a mu
Potential Peanut Allergy Treatment Gives Pharma Company A Boost
08:43pm, Wednesday, 11'th Sep 2019
Most people are aware that peanuts can cause a severe, potentially life-threatening allergic reactions, which can be unpredictable, and even minuscule amounts of peanut can cause a disaster. Aimmune
Stock market news: August 27, 2019
08:11pm, Tuesday, 27'th Aug 2019
U.S. stocks swung into negative territory, ending Tuesday’s session lower after a closely watched portion of the Treasury yield curve inverted further and stoked fears of a recession.
8 ETFs to Capture Opportunities in Healthcare Sector
03:12pm, Thursday, 22'nd Aug 2019
Institutional investors and hedge funds have shifted away from technology names as the U.S.-China trade war extends and picked up battered healthcare names. Retail investors can also gain exposure to
Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?
02:59pm, Wednesday, 07'th Aug 2019
Despite robust results, pharma ETFs have been trending downward in a month.
Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat
02:50pm, Wednesday, 17'th Jul 2019
Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.
